8.085 Views
50 million people worldwide have dementia, with 10 million new cases emerging annually. Alzheimer's disease is the most common form of dementia, but for 20-years, there have been no new drugs to tackle the disorder until now. In June, the US Food and Drug Administration approved Aducanumab, a new Alzheimer's medication. While this is a promising development, fierce debate surrounds its efficacy and approval process. FDA Advisory Committee member Dr. Alexander discusses this controversial drug.
First Air Date : Apr 28, 2020
Last Air date : Dec 07, 2021
Episode : 51 Episode
Season : 2 Season
Runtime: 26:14 minutes
Studio: NHK WORLD-JAPAN
Country:
Cast: Del Irani
Crew: